Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
12 2021
Historique:
received: 24 03 2021
accepted: 13 10 2021
pubmed: 26 10 2021
medline: 15 12 2021
entrez: 25 10 2021
Statut: ppublish

Résumé

Considerable uncertainty surrounds the timeline of introductions and onsets of local transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) globally

Identifiants

pubmed: 34695837
doi: 10.1038/s41586-021-04130-w
pii: 10.1038/s41586-021-04130-w
pmc: PMC8636257
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-132

Subventions

Organisme : NIAID NIH HHS
ID : R56 AI148284
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001137
Pays : United States
Organisme : ACL HHS
ID : U01IP001137
Pays : United States

Commentaires et corrections

Type : UpdateOf
Type : UpdateOf
Type : CommentIn

Informations de copyright

© 2021. The Author(s).

Références

Science. 2020 Oct 30;370(6516):564-570
pubmed: 32912998
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
Nature. 2020 Sep;585(7825):410-413
pubmed: 32365354
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Sci Adv. 2020 Dec 4;6(49):
pubmed: 33158911
J Comput Sci. 2010 Aug 1;1(3):132-145
pubmed: 21415939
J Theor Biol. 2008 Apr 7;251(3):450-67
pubmed: 18222487
Nat Commun. 2020 Oct 9;11(1):5110
pubmed: 33037213
Sci Data. 2020 Aug 27;7(1):285
pubmed: 32855430
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21484-9
pubmed: 20018697
Nat Hum Behav. 2020 Jul;4(7):756-768
pubmed: 32576982
Clin Infect Dis. 2021 Jun 15;72(12):e1004-e1009
pubmed: 33252659
BMC Med. 2020 Jul 30;18(1):240
pubmed: 32727547
Nat Med. 2020 Dec;26(12):1919-1928
pubmed: 33057181
Nature. 2021 Jan;589(7840):82-87
pubmed: 33171481
JAMA. 2020 Sep 1;324(9):859-870
pubmed: 32745200
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Lancet Infect Dis. 2020 Jul;20(7):803-808
pubmed: 32246905
MMWR Morb Mortal Wkly Rep. 2020 Jun 05;69(22):680-684
pubmed: 32497028
Science. 2020 Aug 28;369(6507):1106-1109
pubmed: 32694200
JAMA Intern Med. 2020 Jul 21;:
pubmed: 32692365
Clin Infect Dis. 2022 Mar 1;74(4):584-590
pubmed: 34128970
Sci Total Environ. 2021 Jan 1;750:141711
pubmed: 32835962
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Emerg Infect Dis. 2020 Jul;26(7):1465-1469
pubmed: 32207679
Phys Rep. 2021 May 23;913:1-52
pubmed: 33612922
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
J R Soc Interface. 2021 Feb;18(175):20200822
pubmed: 33620263
Science. 2021 Jan 29;371(6528):466-467
pubmed: 33510015
Nat Commun. 2021 Jan 12;12(1):323
pubmed: 33436609
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
PLoS Comput Biol. 2013;9(1):e1002803
pubmed: 23341757
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
PLoS Comput Biol. 2017 Sep 12;13(9):e1005697
pubmed: 28898249
PLoS One. 2020 Oct 13;15(10):e0240648
pubmed: 33048967
Science. 2021 Feb 12;371(6530):708-712
pubmed: 33419936
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Int J Antimicrob Agents. 2020 Jun;55(6):106006
pubmed: 32371096
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Science. 2021 Apr 23;372(6540):412-417
pubmed: 33737402
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22430-22435
pubmed: 32820074
Cell. 2020 May 28;181(5):990-996.e5
pubmed: 32386545
Elife. 2020 Feb 24;9:
pubmed: 32091395
Nat Commun. 2020 Sep 16;11(1):4674
pubmed: 32938924
BMJ. 2020 Jul 15;370:m2743
pubmed: 32669358
Lancet Glob Health. 2020 May;8(5):e641-e642
pubmed: 32199072
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10484-10491
pubmed: 32327608
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33571105
Nat Med. 2020 Dec;26(12):1829-1834
pubmed: 33020651
BMC Med. 2020 Oct 22;18(1):332
pubmed: 33087179
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Nat Hum Behav. 2020 Dec;4(12):1303-1312
pubmed: 33199859
Science. 2020 May 1;368(6490):493-497
pubmed: 32213647
Euro Surveill. 2020 Aug;25(31):
pubmed: 32762797
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
JAMA. 2020 May 19;323(19):1915-1923
pubmed: 32275295
Lancet Public Health. 2020 Nov;5(11):e612-e623
pubmed: 33065023
Science. 2020 Apr 24;368(6489):395-400
pubmed: 32144116

Auteurs

Jessica T Davis (JT)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Matteo Chinazzi (M)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Nicola Perra (N)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.
Networks and Urban Systems Centre, University of Greenwich, London, UK.

Kunpeng Mu (K)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Ana Pastore Y Piontti (A)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Marco Ajelli (M)

Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.

Natalie E Dean (NE)

Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.

Corrado Gioannini (C)

ISI Foundation, Turin, Italy.

Maria Litvinova (M)

Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA.

Stefano Merler (S)

Bruno Kessler Foundation, Trento, Italy.

Luca Rossi (L)

ISI Foundation, Turin, Italy.

Kaiyuan Sun (K)

Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

Xinyue Xiong (X)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA.

Ira M Longini (IM)

Department of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA.

M Elizabeth Halloran (ME)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Department of Biostatistics, University of Washington, Seattle, WA, USA.

Cécile Viboud (C)

Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

Alessandro Vespignani (A)

Laboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA, USA. a.vespignani@northeastern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH